
Sudarshan Jain
About Sudarshan Jain
Data last updated:
Sudarshan Jain is a Director at Abbott India Limited (since 2019), Director at Encube Ethicals Private Limited (since 2026) and Non- Individual Subscriber at Lifesciences Skill Development Council (since 2026). The companies operate in Pharma, Healthcare and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹8,054 Cr; the largest is Abbott India Limited at ₹6,685 Cr (FY 2025). Earlier, Sudarshan Jain was a Director at Healthium Medtech Limited (2018–2021) and Director at Zcl Chemicals Limited (2018–2021) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2019 | 1944 | ₹6,685 Cr (FY 2025) | Active | |
| Director | 22 May 2026 | 1995 | ₹1,369 Cr (FY 2025) | Active | |
| Non- Individual Subscriber | 25 Aug 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Sep 2018 | 1992 | ₹870 Cr (FY 2025) | Active | |
| Director | 31 Aug 2018 | 1991 | ₹418 Cr (FY 2023) | Amalgamated | |
| Director | 25 Jul 2011 | 1997 | ₹8,811 Cr (FY 2025) | Active | |
| Additional Director | 21 Dec 2009 | 1994 | ₹533 Cr (FY 2026) | Active | |
| Director | 26 Sep 2011 | 1965 | ₹15.58 Cr (FY 2025) | Active | |
| Director | 23 Jul 2010 | 2010 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sudarshan Jain
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudarshan Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudarshan Jain
Sudarshan Jain currently holds 3 directorships: Abbott India Limited (Director, since 01 Apr 2019, revenue ₹6,685 Cr (FY 2025)); Encube Ethicals Private Limited (Director, since 22 May 2026, revenue ₹1,369 Cr (FY 2025)); Lifesciences Skill Development Council (Non- Individual Subscriber, since 25 Aug 2026).
Sudarshan Jain was first appointed on 21 Dec 2009 as Additional Director at Abbvie Therapeutics India Private Limited. The most recent appointment on record is 25 Aug 2026 at Lifesciences Skill Development Council.
The 2 current companies of Sudarshan Jain that report revenue have a combined latest revenue of ₹8,054 Cr: Abbott India Limited ₹6,685 Cr (FY 2025); Encube Ethicals Private Limited ₹1,369 Cr (FY 2025).
Sudarshan Jain held 6 earlier board appointments: Healthium Medtech Limited (Director, 27 Sep 2018 to 26 Aug 2021); Zcl Chemicals Limited (Director, 31 Aug 2018 to 09 Mar 2021); Abbott Healthcare Private Limited (Director, 25 Jul 2011 to 30 Jun 2017); Abbvie Therapeutics India Private Limited (Additional Director, 21 Dec 2009 to 05 Oct 2010); Organisation Of Pharmaceutical Producers Of India (Director, 26 Sep 2011 to 30 Jun 2017); and 1 more.
The current boards of Sudarshan Jain's companies include Alison Elizabeth Davies (Abbott India Limited), Darshan Pravin Gada (Abbott India Limited), James Russell Wenner (Abbott India Limited), Kaiyomarz Minoo Marfatia (Abbott India Limited), Kartik Rajendran (Abbott India Limited), Maithilee Kaizad Mistry (Abbott India Limited), among others.